A Study to Assess the Pregnancy Outcome in Women Exposed to Dayvigo® During Pregnancy Compared to an Unexposed Control Population
Clinical trial NCT06744673 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06744673
- Sponsor
- Eisai Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-03
- Primary completion
- 2025-12-30
- Enrollment
- 861
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.